← USPTO Patent Applications

ANTI-GHRELIN BUTYRYLCHOLINESTERASE ENZYME THERAPEUTIC

Application US20260077059A1 Kind: A1 Mar 19, 2026

Inventors

Matthew Neal

Abstract

Compositions and methods are provided for inactivating ghrelin in mammalian cells by administration of a polynucleotide encoding a butyrylcholinesterase (BChE) enzyme.

CPC Classifications

A61K 48/005 A61K 9/5138 C12N 9/18 C12N 15/85 C12N 15/88 A61K 38/00 C07K 2319/60 C12Y 301/01008

Filing Date

2025-09-15

Application No.

19329487